Dive Into a New Age
of Diagnosis
Imunodig is about agility & sustainability
The advantages are:
1. Proteins gain resistance against thermal and/or chemical inactivation and also gain competence for continuous activity (20 batch guarantee).
2. Different proteins can be encapsulated separately and at the same time e.g. besides mono-enzymatic this invention can work as a multi-enzymatic support.
Can be used in:
Industrial biocatalysis – Enzymes gain stability under industrial harsh conditions, easier separation from the products and possibility of multi-enzymatic systems in one pot.
Medical Diagnosis Devices - Antibodies or cancer biomarkers from the patient´s liquid sample are detected by the encapsulated counterparts antigens or antibodies
Is profitable because:
1. Enzymes for manufacturing (e.g. active pharmaceuticals intermediates) are relevant in industrial budgets and one-pot cascade reactions are possible with this composite.
2. Point-of-Care Test (POCT) market worth in 2017 was 23 billion USD with growth around 10% per annum. Projection of the global POCTs market for 2022: USD 38 billion.
Intelectual Property:
This invention is recognized and protected by an International Patent: The novelty, inventive step and industrial application of all claims were fully recognized before IP international registration request. Patent was granted in Europe. In USA and China under registration.
